Report Description

United Kingdom Stent Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027. The rising incidences of cardiovascular disorders across the United Kingdom are primarily driving the growth of the market. In addition to this, the proliferating cases of several ailments such as ischemic heart disease, peripheral artery disease (PAD), and aortic aneurysm is also adding to the market growth. Moreover, the growing geriatric population across the UK, who are more prone to such ailments, is further adding to the product demand. Apart from this, the sedentary lifestyle, unhealthy eating choices, along with high consumption of alcohol, and smoking habits, are adding to the occurrences of such severe ailments, which eventually is providing a thrust to the United Kingdom stent market.

Stent refers to a small mesh tube that is primarily utilized to open and hold passages in the body, particularly in weak and narrow coronary arteries. This provides the heart with oxygen-rich blood. Stents are generally inserted in an angioplasty procedure where plaque blocks a blood vessel. They are inserted either as an emergency to treat a heart attack or in a planned manner to wide open an artery that is blocked by fatty plaque.

Rising Preferences for Minimally Invasive Procedures Fuel the Market Growth

Growing inclination towards minimally invasive surgeries (MIS) is another major factor anticipated to propel the growth of the United Kingdom stent market over the forecasted period. Minimally invasive procedures involve small incisions with minimal pain, hence leading to higher patient satisfaction. These procedures also facilitate shorter hospital stays and quick recovery. Moreover, technological advancements in stents, such as the utilization of biodegradable materials in stent manufacturing and the development of bifurcated stents, have enabled improved treatment of cardiovascular diseases. Along with this, several companies are increasingly involved in the research and development of innovative products and strategic partnerships collaborations to expand the market reach.

Rising Prevalence of Cardiovascular and Lifestyle Diseases Drives the Product Demand

The increasing aging population in the United Kingdom has resulted in the increased number of patients with cardiovascular diseases as the geriatric population is more prone to such ailments. In 2020, people aged 65+ accounted for the share of 18.65% out of 67.26 million population in United Kingdom. Moreover, the rising cases of hypertension have also resulted in increased incidences of cardiovascular diseases. In addition, the bolstering number of obese people across the United Kingdom due to sedentary and unhealthy lifestyle choices is acting as another major risk factor responsible for CVDs. Excessive fat inside the arteries leads to various health problems such as coronary heart diseases. As a result, the demand for stents is surging across all the healthcare facilities based in the UK, thereby propelling the growth of the United Kingdom stent market. 


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The United Kingdom stent market is segmented by product type, by material type, by type, by end user, competitional landscape, and regional distribution. Based on product type, the market is differentiated between vascular stents and non-vascular stents. By material type market is bifurcated into metal and polymer. Based on the type, the market is fragmented into balloon expandable and self-expandable. By end user the market is divided between hospitals & clinics, ambulatory care centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Company Profile

Medtronic United Kingdom, Abbott Laboratories Limited, Boston Scientific Limited, Becton, Dickinson U.K. Limited, Stryker (UK) Limited, Conmed UK Limited, and B. Braun Medical Limited are the key leading companies of United Kingdom stent market.

 

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, value forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product Type

·         Material Type

·         Type

·         End Users

Regional scope

London, East Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire & Humberside

Key companies profiled

Medtronic United Kingdom, Abbott Laboratories Limited, Boston Scientific Limited, Becton, Dickinson U.K. Limited, Stryker (UK) Limited, Conmed UK Limited, and B.Braun Medical Limited

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom stent market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • United Kingdom Stent Market, By Product Type:
    • Vascular Stents
    •  Non-Vascular Stents
  • United Kingdom Stent Market, By Material Type:
    • Metal
    • Polymer
  • United Kingdom Stent Market, By Type:
    • Balloon Expandable
    • Self-Expandable
  • United Kingdom Stent Market, By Type:
    • hospitals & clinics
    • ambulatory care centers
    • others
  • United Kingdom Stent Market, By Region:

o   London

o    East Anglia

o   Southwest

o   Southeast

o   Scotland

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom Stent Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

United Kingdom stent market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Stent Market

4.    Executive Summary

5.    Voice of Customers

6.    United Kingdom Stent Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Product Type (Vascular Stents v/s Non-Vascular Stents)

6.2.2.     By Material Type (Metal v/s Polymer)

6.2.3.     By Type (Balloon Expandable v/s Self-Expandable)

6.2.4.     By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)

6.2.5.     By Region

6.2.6.     By Company (2021)

6.3.  Product Market Map

7.    United Kingdom Vascular Stents Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Coronary Stents, Peripheral Stents, Neurovascular Stents)

7.2.2.     By Material Type

7.2.3.     By Type

7.2.4.     By End Users

8.    United Kingdom Non-Vascular Stents Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Gastrointestinal Stents, Urological Stents, Pulmonary (Airway) Stents)

8.2.2.     By Material Type

8.2.3.     By Type

8.2.4.     By End Users

9.    Market Dynamics

9.1.     Drivers

9.2.     Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Import-Export Analysis

13.  United Kingdom Economic Profile

14.  Competitive Landscape

14.1.    Medtronic United Kingdom

14.2.    Abbott Laboratories Limited

14.3.    Boston Scientific Limited

14.4.    Becton, Dickinson U.K. Limited

14.5.    Stryker (UK) Limited

14.6.    Conmed UK Limited

14.7.    B.Braun Medical Limited

15.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

United Kingdom stent market is anticipated to grow with an impressive CAGR during the forecast period, 2023-2027, due to the rising prevalence of cardiovascular diseases and several other lifestyle diseases such as obesity and hypertension.

down-arrow

Based on end user, the market is divided between hospitals & clinics, ambulatory care centers, and others. Among these, the hospitals and clinics are expected to dominate the market as a higher number of patients prefer taking proper care in the hospitals and clinics. Moreover, with the increasing number of hospitals and clinics, these facilities are easily accessible.

down-arrow

Medtronic United Kingdom, Abbott Laboratories Limited, Boston Scientific Limited, Becton, Dickinson U.K. Limited, Stryker (UK) Limited, Conmed UK Limited, and B.Braun Medical Limited are the major leaders of the United Kingdom stent market.

down-arrow

New market players may invest actively in research and innovative product development. Also, merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

profile

Sakshi Bajaal

Business Consultant
Press Release

United Kingdom Stent Market May Register an Impressive Growth Through 2027

Aug, 2022

The rising geriatric population along with the rising rate of heart attacks across the United Kingdom is driving the growth of the United Kingdom stent market in the upcoming five years.